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Abstract
Background: Obesity is a major risk factor for many diseases. The paper calculates the economic impact and the
cost per Quality-Adjusted Life Year (QALY) resulting from the adoption of eight interventions comprising the
clinical and part of the community components of the National Prevention and Health Promotion Program
(NPHPP) of the Israeli Ministry of Health (MOH) which represents the obesity control implementation arm of the
MOH Healthy Israel 2020 Initiative.
Methods: Health care costs per person were calculated by body mass index (BMI) by applying Israeli cost data to
aggregated results from international studies. These were applied to BMI changes from eight intervention
programmes in order to calculate reductions in direct treatment costs. Indirect cost savings were also estimated as
were additional costs due to increased longevity of program participants. Data on costs and QALYs gained from
Israeli and International dietary interventions were combined to provide cost-utility estimates of an intervention
program to reduce obesity in Israel over a range of recidivism rates.
Results: On average, persons who were overweight (25 ≤ BMI < 30)had health care costs that were 12.2% above
the average health care costs of persons with normal or sub-normal weight to height ratios (BMI < 25). This
differential in costs rose to 31.4% and 73.0% for obese and severely obese persons, respectively.
For overweight (25 ≤ BMI < 30) and obese persons (30 ≤ BMI < 40), costs per person for the interventions
(including the screening overhead) ranged from 35 NIS for a community intervention to 860 NIS, reflecting the
intensity of the clinical setting intervention and the unit costs of the professionals carrying out the intervention [e.
g., dietician]. Expected average BMI decreases ranged from 0.05 to 0.90. Higher intervention costs and larger BMI
decreases characterized the two clinical lifestyle interventions for the severely obese (BMI ≥ 40).
A program directed at the entire Israeli population aged 20 and over, using a variety of eight different
interventions would cost 2.07 billion NIS overall. In the baseline scenario (with an assumed recidivism rate of 50%
per annum), approximately 620,000,000 NIS would be recouped in the form of decreased treatment costs and
indirect costs, increased productivity and decreased absenteeism. After discounting the 89,000,000 NIS additional
health costs attributable to these extra life years, it is estimated that the total net costs to society would be 1.55
billion NIS. This total net cost was relatively stable to increases in the program’s recidivism rates, but highly
sensitive to reductions in recidivism rates.
Under baseline assumptions, implementation of the cluster of interventions would save 32,671 discounted QALYs
at a cost of only 47,559 NIS per QALY, less than half of the Israeli per capita GNP (104,000 NIS). Thus
implementation of these components of the NPHPP should be considered very cost-effective.
Conclusion: Despite the large costs of such a large national program to control obesity, cost-utility analysis
strongly supports its introduction.
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Background
The increasing prevalence of obesity is an important
public health problem that contributes to excess mor-
bidity and mortality world-wide [1,2]. Obesity (30<
BMI), and overweight (25 < BMI < 30) are major risk
factors for morbidity and mortality. Calculations based
on disease and gender specific relative risks from a
recent meta-analysis of internationally published data
[3] adjusted to Israeli demographic data, estimated that
obesity and overweight and account for around 3,105
deaths (95%CI 2,415-4,266) per year in Israel (7.7% of
all deaths). After adapting Canadian Cost of Illness [4]
data to Israeli economic conditions, the costs of treat-
ing morbidity due to obesity and overweight in Israel
amount to NIS 1.92 billion (95%CI: 4.29-8.33), equal to
0.24% (95% CI 0.18%-0.35%) of the GDP, or 3.05%
(95% CI 2.29%-4.45%) of Israel’s health expenditures.
Additional costs of NIS 1.89 billion have been esti-
mated to be due to productivity losses, and a further
NIS 1.95 billion results from other indirect costs..
Thus the total costs attributable to obesity and over-
weight amount to approximately NIS 5.76 (95%CI:
4.29-8.33), equal to about 0.73% (95%CI 0.54%-1.05%)
of the Israeli GDP.
In 2005, the Ministry of Health established the
Healthy Israel 2020 initiative to develop a national pre-
ventive health targeting program for Israel. Twenty
committees covering a broad spectrum of health
domains were formed. The Health Behaviors Committee
created eight subcommittees, each dealing with key life-
style behavior risks such as obesity, tobacco use and
sedentariness, among others. Health burden-based
objectives, quantifiable targets, and science-based and
practicable interventions were selected to reduce the
respective health (and economic) burdens. A National
Prevention and Health Promotion Program (NPHPP) to
control obesity, encourage healthful nutrition, and
enhance physical activity has been jointly developed by
the Ministries of Health, Education, and Culture &
Sports.
The NPHPP interventions to prevent and control obe-
sity can be broadly grouped into three domains:
A. The clinical sphere. Examples include screening,
counseling, and medical interventions [such as the
prescription of Orlistat, the only currently certified
weight loss medication], as well as surgical
interventions
B. The community. Examples include home, school,
workplace, restaurant and supermarket- based inter-
ventions, media strategies, and other initiatives
initiated by community-based organizations such as
municipal governments and NGO’s
C. The legislative sphere. Examples include taxation
of unhealthful food products [5], provision of gov-
ernment subsidies to reduce the price of healthful
foods [and vice-versa] [6], mandatory food labeling
[7], and prohibiting the sale of unhealthful foods in
vending machines [8,9].
Nationwide community or clinic-based interventions
to reduce obesity can be costly due to the large numbers
of people targeted. These high intervention costs form a
barrier to the adoption of such programs by government
funding agencies (e.g., Ministries of Finance). However,
adoption of such programs have the potential not only
to generate additional QALYs (quality adjusted life
years) but to also reduce treatment costs for diseases
directly associated with obesity (e.g., diabetes, hyperten-
sion, etc.). In addition, it is likely that further savings
will accrue due to productivity gains secondary to
decreased presenteeism and absenteeism. Further mone-
tary savings should accrue on account of reduced costs
of informal care givers in the community, delayed burial
costs, and other indirect costs.
While adding extra QALYs is of paramount impor-
tance, interventions that are cost-saving (viz., averted
direct and indirect costs exceed intervention costs) or
whose net cost (i.e., intervention cost less direct and
indirect savings) is low are the ones more likely to be
funded.
Recent publications [10-12] have prioritized these
interventions by calculating their cost-effectiveness
ratios in the form of costs per QALY.
On the other hand, cost-effectiveness analyses of fiscal
incentives such as subsidizing healthful foods or taxing
unhealthful ones and legislative interventions such as
food labeling or banning the sale of unhealthful pro-
ducts in school vending machines were not found in the
international scientific literature.
This study then seeks to calculate the expected costs
and cost-utility of the implementation of various clinical
and community-based intervention strategies forming
part of the interventional suite currently recommended
by the tri-ministerial NPHPP to reduce the burden of
obesity in Israel.
Methods
Calculation of excess health costs by BMI category
Sixteen studies from various countries and time periods
that reported on the relationship between Body Mass
Index (BMI) and health service expenditures [13-28]
were identified. The reported data were interpolated and
indexed to a standard scale where an average normal
BMI value of 22.5 was given an index value of 100. The
average of each BMI specific value was then taken to
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provide a combined index relating health service expen-
ditures with BMI levels.
The BMI prevalence distribution for adults aged 20
and above [Personal Communication, Dr Tami Shohat,
Israel Centre for Disease Control] was multiplied by the
total adult population aged 20 and above in 2010 of
4,835,024 persons [29,30] in order to estimate the num-
ber of adults within each unit BMI category.
The estimated total of 1.92 billion NIS additional
health care costs attributable to obesity (1,145 million
NIS) and overweight (773 million NIS) were distributed
over the entire BMI spectrum in proportion to the num-
ber of persons and the excess health care costs in each
BMI unit category. Both total costs and average costs
per person in each BMI category were calculated,
enabling us to calculate the marginal change in health
care costs per unit change in BMI. All costs are pre-
sented in New Israeli Shekels (NIS) at mid-2010 price
levels (Exchange rate 3.729 NIS to the US dollar).
Allocation of persons to cost-saving and very cost-
effective interventions
All eight office-based and community and dietary inter-
ventions [10,31-34] that had been identified as being
either cost-saving or very cost-effective in a previous
comprehensive study of the cost-utility of interventions
[10] were selected in order to estimate their impact on
costs when implemented on a national level as part of
the NPHPP. Brief descriptions of the interventions are
provided in Appendix 1. Two studies that had been
identified as being very cost-effective were not included
among the eight selected studies on the grounds that
one [35] was based on the combined results of a prior
included study [32] and the other was based in a clinical
drug trial setting [36] that cannot be replicated in rou-
tine public health interventions.
It was assumed that the 52,517 severely obese (BMI ≥
40) persons would be allocated equally between the
standard and low carbohydrate dietary interventions
[34]. The remaining 4,782,506 persons in the population
would be distributed equally (i.e., 797,084 persons per
intervention) among each of the other six interventions.
Therefore we are creating an estimate based on the
assumption that Israel adopts a multiplicity of interven-
tions (that have previously succeeded abroad) in equal
numbers.
In the intervention where initial screening costs for
identifying persons who were overweight or obese were
omitted [33], a cost of 5.4 NIS per person screened was
added, based on the estimated Israeli costs of three min-
utes screening time (50% by physicians and 50% by
nurses) [10] Full details of the intervention specific cost
and QALY estimates are given in our companion source
paper [10].
Costs per QALY definitions
The costs of the interventions were adjusted to Israeli
NIS by the country-specific consumer price index to
2010 price levels and by the appropriate exchange rate
which took into account purchasing power parities
(PPP) for the non-tradable [e.g., manpower] elements of
the interventions. Costs per QALY gained were calcu-
lated by indexing the results of a prior comprehensive
cost-utility study based on 2008 price levels [10] to 2010
price levels [30]. An intervention was defined as being
cost-saving if it yields actual savings as well as contri-
buting additional QALYs, very cost-effective if the cost
per QALY is less than the Israeli per capita GNP of NIS
104,161 in 2010 [37] or cost-effective [if the cost per
QALY is between 1-3 times the per capita GNP (NIS
104,161-312,483). If the cost per QALY is more than
three times the GNP per capita (> NIS 312,483) then
the intervention is regarded as not being cost-effective.
Calculation of treatment cost savings by BMI level
Total (gross) intervention costs were calculated by mul-
tiplying the numbers targeted by the unit costs of the
intervention, thereby implicitly assuming an ideal cover-
age rate of 100%. Absolute effects of the interventions
on BMI were calculated directly from the specific study
reports on changes in BMI [18,32,33], or indirectly via
weight changes [35] and QALYS lost from morbidity
due to elevated BMI [10]. Lifetime savings in health
treatment costs by intervention were based on the mar-
ginal health care costs saved per BMI change multiplied
by the intervention-specific BMI change. Future years’
savings in health expenditures were calculated using a
3% per annum discount rate.
There is a paucity of data on long-term recidivism
rates after the cessation of intervention programs against
obesity. The efficacy data in the studies that were used
in this paper were based on intervention studies of up
to only one year duration, with modeling techniques in
some studies extrapolating the outcomes over longer
periods of time.
A baseline 50% per annum recidivism rate, was
selected (with a sensitivity analysis performed in the
range of 20%-80% per annum) as a conservative estimate
based on the following information:
i) An implied recidivism rate of 4.0% per annum was
derived from a meta-analysis of studies using diet
alone, which reported an average weight loss of 4.5
kg at six months, which was reduced by only 13% to
3.9 kg after four years [38].
ii) Studies using diet and exercise reported a 7.9 kg
loss at six months that was reducedby 33% to 4.5 kg
after four years- implying a 15.0% recidivism rate
[38].
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iii) The successful maintenance of a weight loss of
7% or more 2.8 years after an intensive lifestyle
intervention by 37% of overweight individuals with
impaired glucose intolerance [39] - implying a reci-
divism rate of 30.2%.
iv) A reported 13%-20% of persons who maintained
a weight loss of at least 5 kg for five years [40]. This
is equivalent to an annual recidivism rate between
33%-40%.
v) Data from the US national weight control registry
indicate a one-year recidivism rate of 35% (defined
as gaining 2.3 kg or more), while 59% maintained
their body weight and 6% continued to loss more
weight [41].
vi) Research indicating that approximately 20% of
overweight individuals are successful at long-term
weight loss, defined as losing at least 10% of initial
body weight and keeping the weight off for at least
one year - implying an 80% recidivism rate [40,42].
Indirect costs
Averted productivity losses were based on 98.8% of esti-
mated direct health care savings [4]. Similarly, averted
care costs and other indirect costs were estimated to be
80% and 22% of productivity losses [4]. Net costs to
society were calculated by deducting all these averted
direct and indirect costs from the gross intervention
cost. A sensitivity analysis was performed on a range of
recidivism rates from 10%-90% per annum.
Converting BMI changes to QALY gains
BMI unit values were assigned QALY weights by inter-
polating the values (Table 1) from a UK study [34]. This
allowed for marginal QALY improvements per unit
decrease in BMI and hence total lifetime QALY gains
(discounted at 3% per annum) and cost per QALY per
intervention to be calculated. Additional life expectancy
per BMI change (0.415 years per unit BMI) was based
on the average value extracted from two studies [33,35]
that reported very similar values of an additional 0.41
and 0.42 extra life years per unit BMI decrease, based
on reported increased life expectancy and BMI decreases
[30] and QALY increases [35]. These intervention speci-
fic estimates of increased life expectancy were then con-
verted to QALYs by adjusting by the appropriate Health
Adjusted Life Expectancy (HALE) multipliers (that take
into account the background decrease in functioning
due to aging) and the appropriate BMI to QALY ratio
[43].
On an assumption (based on expert opinion as to the
ideal age group for intervene with weight control pro-
grams) that the average age of a participant in the pro-
gram was 52 years, and that each had, on average, a
residual life expectancy of 30 years [30], we estimated
the additional (discounted) health-care costs due to the
increased life expectancy of those persons who reduced
their BMI.
Excess years gained due to the interventions were
assumed to have the characteristic of having average
health costs of the treated targeted cohort (i.e., over-
weight/obese or severely - obese).
Results
Overweight individuals bore health care costs that were
12.2% above the those of persons with normal or below-
normal weight to height ratios (BMI < 25). This percen-
tage rose to 31.4% and 73.0% for obese (30 ≤ BMI < 40)
and severely obese persons (BMI ≥ 40), respectively
(Table 2). For example, an obese person with a BMI of
37.5 would incur an additional 1,672 NIS in health care
expenditures per year. If, however, as a result of partici-
pation in an intervention program the person’s BMI
drops by 1 kg/m2 to 36.5, their health expenditures
would be expected to fall by 109 NIS (i.e.,: 1,672-1,563)
per year (Table 1).
For overweight individuals and obese persons with
BMI < 40, costs per person for the interventions
(including the screening overhead) ranged from 35 NIS
(for a multifaceted community intervention) to 860 NIS
(Table 3), for an intensive clinical setting intervention,
including the unit costs of the professionals carrying out
the intervention (e.g., dietician). The interventions ran-
ged from being cost-saving to being a very cost-effective
50,543 NIS per QALY. Expected average BMI decreases
ranged from 0.05 to 0.90 (Table 3). Higher intervention
costs, higher costs per QALY, and larger BMI decreases
characterized the two clinical lifestyle interventions for
the severely obese (BMI ≥ 40) (Table 2).
Implementation of the NPHPP to cover the entire
Israeli population aged over 20 years with a combination
of six different interventions would cost 2.07 billion NIS
(Table 4). Approximately 201,000,000 NIS would be
recouped in the form of decreased treatment costs and
a further 199,000,000 NIS would be regained via
increased productivity and decreased absenteeism. Other





20 or less Underweight 0.741
20 to 24.9 Desirable 0.787
25 to 29.9 Overweight 0.769
30 to 34.9 Obese Class I 0.707
35 to 39.9| Obese Class II 0.672
≥ 40 Obese Class III (morbidly/extremely
obese)
0.624
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averted indirect costs account for the saving of an extra
202,000,000 NIS. The discounted health costs attributa-
ble to additional life expectancy as a result of BMI
reductions, amount to approximately 89,000,000 NIS.
Therefore, the total net costs of the interventions to
society will be 1.55 billion NIS.
If the recidivism rate is reduced to 35% or 20%, net
societal costs will fall to 1.35 billion and 0.89 billion,
respectively. On the other hand, if recidivism rates reach
65% or 80%, net societal costs will increase slightly to
1.67 and 1.74 billion NIS, respectively (Table 5).
In the baseline 50% recidivism scenario, 32,671
QALYs would be saved by implementing the interven-
tions, at an average cost of 47,559 NIS per QALY
(Table 5), less than half the per capita annual GNP [24].
Decreased recidivism rates of 35% and 20% will increase
the numbers of QALYS saved to 45,567 and 75,150
respectively, and decrease costs per QALY to 29,661
and 11,812 NIS per QALY respectively.
Increased recidivism rates of 65% and 80% will
decrease the numbers of QALYS saved to 25,464 and
20,862 respectively, while increasing costs per QALY to
65,457 and 83,355 NIS per QALY (Table 5), which are
both considered as being very cost-effective ratios.
Discussion
In the baseline case, assuming an annual recidivism rate
of 50%, the total intervention costs of eight weight loss
programs aimed at the entire adult population of Israel,
amount to 2.07 billion NIS. The costs of such a large
program are likely to be spread over a period of time,
say five or ten years, due to manpower and budgetary
constraints. Approximately 29.1% of these costs would
be offset by averted direct and indirect costs attributable
to obesity. However, after treatment costs due to
increased longevity are taken into account, these saving
would be reduced by only about one-quarter (24.8%) of
the intervention costs.
Our assumption of 100% coverage is a reasonable one
given Israels small size and universal health insurance
coverage. In reality, compliancy with some programs
will fall short of 100%, but this has been implicitly
recognized in the cost and QALY values taken from the
source studies (10).
Our assumption of a continual geometric decrease in
recidivism could also be considered as being conserva-
tive since weight loss maintenance may get easier over
time; after successfully maintaining weight loss for 2-5
years, the chance of long-term success generally
increases [40,41].
A sensitivity analysis on recidivism rates showed the
total net cost is relatively inelastic with respect to
changes in the recidivism rate above the baseline 50%
levels; a 60% increase in recidivism (increasing the rate
from 50% to 80%) only causes a 12% increase in the net
costs to society. However, reducing recidivism by 60%,
(reducing the estimate from 50% to 20%), which may be
achievable by adding a maintenance component to exist-
ing programs, would have a more elastic impact on
costs, reducing them by 43%. Sixty percent increases
and decreases n recidivism would reduce and increase
QALY gains by 44% and 65%, respectively.







Population Health Care Costs of
Obesity or Overweight
Total per person
(a) (b) (c) (d) (e)
< 19 n.a. 2.4% 115,576 n.a. n.a.
19 94% 2.5% 121,863 0 0
20 96% 4.6% 220,030 0 0
21 98% 5.3% 258,233 0 0
22 100% 7.2% 345,761 0 0
23 103% 8.7% 420,717 0 0
24 106% 9.8% 473,911 0 0
25 108% 9.8% 473,427 123,593,389 261
26 110% 8.9% 429,905 145,645,761 339
27 112% 8.2% 395,570 156,151,524 395
28 115% 7.2% 346,729 171,456,620 494
29 119% 6.0% 292,084 175,690,848 602
30 123% 4.9% 238,890 196,332,658 822
31 126% 3.1% 149,911 141,832,838 946
32 129% 2.4% 116,060 123,015,268 1060
33 133% 2.5% 120,412 144,311,733 1198
34 137% 1.4% 66,734 88,051,773 1319
35 140% 1.5% 72,054 103,825,223 1441
36 143% 1.1% 51,117 79,881,318 1563
37 146% 0.78% 37,813 63,208,344 1672
38 149% 0.39% 18,906 33,668,568 1781
39 154% 0.35% 16,806 32,499,750 1934
40 158% 0.23% 11,204 23,329,496 2082
41 162% 0.12% 5,602 12,496,246 2231
42 166% 0.19% 9,103 21,657,584 2379




(a) Based on the average of sixteen articles [13-28].
(b) Calculations based on Israeli survey data (Personal communication. Dr T.
Shohat).
(c) Column (b) multiplied by 4,835,024 persons [29,30] aged over 20
(d) Excess costs ((a) less 100%) multiplied by population (c) and factors that
result in a total of 772,538,141 NIS and 1,144,775,101 NIS [4] additional health
care costs attributable to overweight and obesity, respectively.
(e) Column (d)/Column (c)
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A growing body of literature supports the notion that
the factors leading to recidivism may be different and
more challenging than those faced during the initial
months to one year of weight loss [44]. Therefore the
prevention of recidivism merits separate intervention
studies (such as maintenance therapy) and cost-effec-
tiveness analyses.
The effectiveness (and resulting cost-effectiveness
ratios) generated by the interventions listed in this
paper may be overstated or understated. The seven non-
Table 3 Costs (NIS at 2010 price levels) and Effects of Dietary Interventions to Reduce Obesity.










25 ≤ BMI < 40 (f)
Clinical setting
Nutritional counseling
Various staff providing nutritional counseling over one year, modeled over lifetime Ginsberg [10] (a,
d)
57 50,543 0.05
General practitioner-based nutritional counseling over one year, modeled over lifetime Olsen [33] (c) 395 4,379 0.22
Dietician-based nutritional counseling, over one year, modeled over lifetime Olsen [33] (c) 860 31,982 0.07





Combined nutritional counseling and office support
Counseling by primary care internists trained in nutrition counseling with an office-support
program tracked for one year Cost-utility estimates based on Israeli data
Ockene [31] (b,
d)
74 < 0 0.81
Community setting
Community-based strategy using mass media campaigns, social support, risk factor screening








Medical center staff counseling to adhere to a low carbohydrate diet over one year. Time
horizon for cost utility analysis also one year
Tsai 2003 [34] (c) 5,767 39,591 1.59
Medical center staff counseling to adhere to Standard NCEP 1 diet [g] over one year. Time
horizon for cost utility analysis also one year
Tsai 2003 [34] (c) 5,584 38,759 0.97
Notes: CS = Cost Saving
(a) Based on primary Israeli epidemiological, demographic and cost data.
Effectiveness from meta-analysis of international studies.
(b) Based on primary Israeli epidemiological and demographic data.
Cost data updated and converted to Israel 2010 price levels. Effectiveness from international study.
(c) Based on international data converted to Israel 2010 price levels.
(d) Based on cost per QALY at average 10 year AMI risk of 12.8% at age 55.
(e) Includes initial screening charge of 5.4 NIS per head [10].
(f) Ref [10] updated to 2010 price levels. All values are ACERs, average cost-effectiveness ratios.




























Ginsberg 10 797,084 45,119,420 4,648,779 4,592,029 3,656,496 1,016,092 2,013,874 33,219,898
Ockene 31 797,084 58,750,777 71,154,890 70,286,270 55,966,868 15,552,459 30,824,650 -123,385,060
J-van der Bruggen I 32 797,084 27,975,847 13,176,831 13,015,976 10,364,235 2,880,085 5,708,269 -5,753,012
J-van der Bruggen II 32 797,084 635,754,990 79,060,989 78,095,855 62,185,409 17,280,510 34,249,611 433,381,838
Olsen I 33 797,084 315,120,819 19,714,059 19,473,401 15,506,090 4,308,939 8,540,228 264,658,558
Olsen II 33 797,084 685,335,609 5,877,750 5,805,998 4,623,143 1,284,711 2,546,270 670,290,278
Tsai I 34 26,259 151,434,528 4,611,477 4,555,182 3,627,156 1,007,939 3,427,595 141,060,368
Tsai II 34 26,259 146,623,901 2,803,055 2,768,836 2,204,742 612,669 2,083,440 140,318,039
TOTAL 4,835,024 2,066,115,891 201,047,829 198,593,546 158,134,140 43,943,405 89,393,937 1,553,790,908
Baseline case of 50% recidivism per year.
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Israeli programs were modeled using observations and
assumptions germane to the health care systems and
cultures in which they were performed. Hence they may
not be completely relevant to the Israeli setting. This
may even be true to some degree with respect to the
lone Israeli-based screening and dietary intervention
[10], as it predicated upon a meta-analysis of the effect
of interventions on LDL cholesterol in international
studies.
On account of the high intervention costs but rela-
tively low cost savings, readers of this study could con-
ceivably decide not to field the proposed suite of
interventions. Yet further examination reveals that
although only one of the eight interventions is cost-sav-
ing [31] the others are all very-cost effective (even when
assuming high recidivism rates) and are therefore worth
adopting. They compare very favorably with the most
cost-effective interventions identified to reduce damage
from smoking [11] and to enhance physical activity [12].
In addition, the gain of roughly 32,671 QALYs, which
reflects decreases in morbidity and mortality, should be
considered a highly desirable benefit of the proposed
intervention program.
A recent OECD document confirmed that counseling
people at risk in the primary care setting was one of the
most effective and cost-effective ways of improving
health [45]. If a long-term time perspective is used,
other interventions such as school-based interventions,
food advertising regulation, worksite interventions, food
labeling and mass media campaigns may also be consid-
ered cost-effective with respect to their impact on obe-
sity. In addition, fiscal measures, such as taxing
unhealthful foods would be a cost-saving intervention
that increases quality of life without incurring extra
costs to society [5]
Finally it should be emphasized that current interna-
tional and HI2020/NPHPP recommended interventions
for weight loss include both dietary and physical activity
(PA) components. A companion study will be addres-
sing the latter, and it is expected that the insights of
both studies will be merged to provide comprehensive
CUA data for the complete suite of interventions.
Conclusions
Fielding an eight-pronged combined clinical and com-
munity-based dietary interventional program within the
context of the National Program for Health Promotion
and Prevention would save over thirty-thousand quality-
adjusted life-years, and is very cost-effective. Yet imple-
mentation would require a substantial long-term mone-
tary investment by the government. The approximations
and extrapolations conducted on the basis of non-Israeli
data support future studies geared towards the genera-
tion of Israeli epidemiologic and cost modeling data.
That said, the overall very cost effective cost-utility esti-
mate of this analysis strongly supports the adoption of
the proposed national program to combat obesity.
Appendix 1: Dietary interventions
Model incorporating Israeli obesity control data
Ginsberg [10] constructed an intervention model esti-
mating the cost per QALY of dietary interventions
[using reductions in LDL-C levels as an intermediate
marker] on the basis of primary Israeli data. It was
assumed that everyone aged 20 and above [n =
4,633,593] would have their waist circumference and
BMI measured. The 14.8% [685,772 obese persons] with
a BMI ≥ 30 would then receive dietary counseling. The
cost of the dietary intervention was based on the client
making two visits during the first three months and
then monthly visits thereafter. Based on common Israeli
practice, it was assumed that 50% of the visits would be
to a physician, 25% to a trained nurse, 20% to a dieti-
cian, and the remaining 5% to a psychologist.
Table 5 Net Costs per QALY of Interventions by Recidivism Rate.
Recidivism Rate 20% 35% 50% 65% 80%
Intervention Costs 2,066,115,891 2,066,115,891 2,066,115,891 2,066,115,891 2,066,115,891
less Savings
Direct Treatment -462,448,210 -280,406,001 -201,047,829 -156,699,045 -128,379,941
Productivity Losses -456,802,895 -276,982,958 -198,593,546 -154,786,149 -126,812,748
Carer Costs -363,738,572 -220,553,299 -158,134,140 -123,251,611 -100,977,223
Other Costs -101,078,183 -61,288,872 -43,943,405 -34,250,008 -28,060,247
plus longevity Costs 205,623,043 124,679,767 89,393,937 69,674,687 57,082,876
Total Savings -1,178,444,816 -714,551,362 -512,324,983 -399,312,125 -327,147,283
Net Costs 887,671,075 1,351,564,529 1,553,790,908 1,666,803,766 1,738,968,608
QALYS saved 75,150 45,567 32,671 25,464 20,862
Net Costs per QALY 11,812 29,661 47,559 65,457 83,355
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International interventions adapted to the Israeli setting
In the USA, Ockene [31] evaluated the effect of nutri-
tional counseling offered by primary care internists
offered training in nutritional counseling and aided by
an office-support program on the saturated fat intake,
weight, and serum lipid measurements of hyperlipi-
demic patients over one year. Net costs per reduction
in LDL-C levels were calculated. The model developed
for the Israeli dietary intervention [4], was then used
to calculate the resultant costs per QALY of the
intervention.
Van-der Bruggen’s Dutch lifestyle intervention model
[32] projected the costs and effects of both a commu-
nity-based lifestyle program for the general population
and an intensive lifestyle intervention for obese adults,
implemented in a health care setting.
Olsen’s Danish study [33] randomized 60 GPs either
to provide nutritional counseling or to refer patients to
a dietician for counseling.
Severely Obese
Tsai et al. compared a low-carbohydrate diet (under 30
grams/day) with the National Cholesterol Education
Program Step I low fat diet for treating severe obesity
[34] in a medical center setting. Study participants
received weekly group counseling sessions during the
first month, followed by monthly group sessions for the
next five months.
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